Pharmaceutical wholesalers struggling to improve bottom lines

Drug wholesalers are finding it increasingly difficult to boost their bottom line amid growing financial costs and credit card fees, analysts said.

To make matters worse, the nation’s average drug manufacturers are likely to see their combined sales fall by around 80 billion won this year due to government-imposed price cuts which took effect in April.

Under such circumstances, 20 pharmac...